Ipsen Biopharmaceuticals announced on Thursday the U.S. FDA approval of IQIRVO (elafibranor), marking the entry of the first non-bile acid derivative ...
Financial News Archive
SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
# FDA Approves Geron Corporation's RYTELO (imetelstat sodium) for Telomerase-Targeted Therapy Geron Corporation received FDA approval for RYTELO (ime...
# FDA Approves Generic Carbidopa and Levodopa from Advagen Pharma Advagen Pharma Ltd has received FDA approval for its generic formulation of carbido...
FDA approved ALMAJECT’s therapeutic product NDA218771, signaling a new addition to the market with potential to address significant unmet medical need...
Alembic Pharmaceuticals Inc. has gained final FDA approval to manufacture and market the oral generic version of Methotrexate Sodium, a pivotal approv...
# FDA Approves IPCA Laboratories' Generic Drug Application IPCA Laboratories Limited received FDA approval for an abbreviated new drug application (A...
Novugen Pharma (USA) LLC has secured FDA approval for its Abbreviated New Drug Application #ANDA216637, generic MYCOPHENOLIC ACID (MYCOPHENOLATE SODIU...
On Wednesday, Amgen Inc announced that the U.S. FDA approved BKEMV (eculizumab-aeeb) injection, expanding its portfolio of rapid-acting, interchangeab...
BIOCON BIOLOGICS INC announced the FDA approval of its generic version of WARRIOR PHARMA INC.'s Granix (filgrastim-sndz) on Wednesday, likely sparking...
# FDA Approves Elite Laboratories' Generic Methotrexate Sodium Oral Formulation Elite Laboratories, Inc. has received FDA approval for its generic me...
AMGEN announced on May 16, 2024, that it has received FDA approval for its investigational new drug, signaling a significant entry into the targeted o...
Epic Pharma LLC has received FDA approval for an Abbreviated New Drug Application (ANDA 218023), projecting an impact on the market as the company man...
Dr. Reddy's Laboratories received FDA approval for its intravenous vasopressin generic, positioning the company to immediately capture market share in...
Ingenus Pharmaceuticals has received FDA approval for the Abbreviated New Drug Application (ANDA 215571) targeting albuterol sulfate inhalation powder...
# FDA Approves Neurocrine Biosciences' INGREZZA SPRINKLE for Tardive Dyskinesia Treatment Neurocrine Biosciences, Inc. has received FDA approval for ...
Attribution of this breakthrough can be reserved for the **AbbVie** approval of the oral rheumatoid arthritis therapy RINVOQ (upadacitinib). The nod r...
ALTOR BIOSCIENCE, LLC received FDA approval for its investigational therapy on April 22, marking a commercial milestone that could significantly bolst...
Scienture LLC announced FDA approval for REZENOPY, a generic naloxone hydrochloride nasal spray, marking the company’s entry into the rapid-growth mar...
La Jolla Pharmaceutical Company secured FDA approval for ZEVTERA (ceftobiprole medocaril sodium), positioning itself in the IV antibiotic market to ad...
# FDA Approves Akebia Therapeutics' VAFSEO for Anemia Treatment The FDA has approved Akebia Therapeutics' VAFSEO (vadadustat), an oral hypoxia-induci...